Detalhe da pesquisa
1.
Insight into the mechanism of CD34+ cell mobilisation impairment in multiple myeloma patients treated with anti-CD38 therapy.
Br J Haematol
; 204(4): 1439-1449, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37807708
2.
Identification of patients at high risk of secondary extramedullary multiple myeloma development.
Br J Haematol
; 196(4): 954-962, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34726261
3.
Bone metabolism parameters and their relation to cytogenetics in multiple myeloma.
Eur J Haematol
; 109(1): 75-82, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35306691
4.
Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice.
BMC Cancer
; 21(1): 73, 2021 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33451293
5.
CD38-negative relapse in multiple myeloma after daratumumab-based chemotherapy.
Eur J Haematol
; 99(2): 186-189, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28470777
6.
Prospective study of signalling pathways in myeloma bone disease with regard to activity of the disease, extent of skeletal involvement and correlation to bone turnover markers.
Eur J Haematol
; 97(2): 201-7, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26613192
7.
Diagnostic deep-targeted next-generation sequencing assessment of TP53 gene mutations in multiple myeloma from the whole bone marrow.
Br J Haematol
; 189(4): e122-e125, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32130732
8.
Retinal oxygen saturation in monoclonal gammopathies patients: A pilot study.
Acta Ophthalmol
; 101(2): e143-e153, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36004612
9.
Ixazomib, Lenalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma in Routine Clinical Practice: Extended Follow-Up Analysis and the Results of Subsequent Therapy.
Cancers (Basel)
; 14(20)2022 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36291949
10.
A rare case of bifocal, extramedullary and hyposecretory relapse of multiple myeloma.
Clin Case Rep
; 9(8): e04570, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34401156
11.
COVID-19 in 96 Patients With Hematologic Disease: The First Single-center Experience From the Czech Republic.
Clin Lymphoma Myeloma Leuk
; 21(9): 606-612, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34083176
12.
Whole-genome optical mapping of bone-marrow myeloma cells reveals association of extramedullary multiple myeloma with chromosome 1 abnormalities.
Sci Rep
; 11(1): 14671, 2021 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34282158
13.
Single agent daratumumab in advanced multiple myeloma possesses significant efficacy even in an unselected "real-world" population.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
; 163(3): 279-283, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30397362
14.
Prospective comparison of conventional radiography, low-dose computed tomography and magnetic resonance imaging in monoclonal gammopathies.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
; 160(2): 305-9, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26740048
15.
Urine immunofixation negativity is not necessary for complete response in intact immunoglobulin multiple myeloma: Retrospective real-world confirmation.
Int J Lab Hematol
; 43(5): e244-e247, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33452712